163 related articles for article (PubMed ID: 28950243)
1. Design, synthesis, and evaluation of novel ursolic acid derivatives as HIF-1α inhibitors with anticancer potential.
Chi KQ; Wei ZY; Wang KS; Wu J; Chen WQ; Jin XJ; Piao HR
Bioorg Chem; 2017 Dec; 75():157-169. PubMed ID: 28950243
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, and screening of novel ursolic acid derivatives as potential anti-cancer agents that target the HIF-1α pathway.
Wu J; Zhang ZH; Zhang LH; Jin XJ; Ma J; Piao HR
Bioorg Med Chem Lett; 2019 Mar; 29(6):853-858. PubMed ID: 30728113
[TBL] [Abstract][Full Text] [Related]
3. Ursolic acid sensitized colon cancer cells to chemotherapy under hypoxia by inhibiting MDR1 through HIF-1α.
Shan JZ; Xuan YY; Zhang Q; Huang JJ
J Zhejiang Univ Sci B; 2016 Sep; 17(9):672-82. PubMed ID: 27604859
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and evaluation of the HIF-1α inhibitory activities of novel ursolic acid tetrazole derivatives.
Zhang LH; Zhang ZH; Li MY; Wei ZY; Jin XJ; Piao HR
Bioorg Med Chem Lett; 2019 Jun; 29(12):1440-1445. PubMed ID: 31006525
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and Biological Evaluation of Novel Ursolic acid Derivatives as Potential Anticancer Prodrugs.
Yang X; Li Y; Jiang W; Ou M; Chen Y; Xu Y; Wu Q; Zheng Q; Wu F; Wang L; Zou W; Zhang YJ; Shao J
Chem Biol Drug Des; 2015 Dec; 86(6):1397-404. PubMed ID: 26077799
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, evaluation, and molecular docking of ursolic acid derivatives containing a nitrogen heterocycle as anti-inflammatory agents.
Wei ZY; Chi KQ; Wang KS; Wu J; Liu LP; Piao HR
Bioorg Med Chem Lett; 2018 Jun; 28(10):1797-1803. PubMed ID: 29678461
[TBL] [Abstract][Full Text] [Related]
7. Shikonin suppresses proliferation and induces cell cycle arrest through the inhibition of hypoxia-inducible factor-1α signaling.
Li MY; Mi C; Wang KS; Wang Z; Zuo HX; Piao LX; Xu GH; Li X; Ma J; Jin X
Chem Biol Interact; 2017 Aug; 274():58-67. PubMed ID: 28684144
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis of novel celastrol derivatives and study on their antitumor growth through HIF-1α pathway.
Shang FF; Wang JY; Xu Q; Deng H; Guo HY; Jin X; Li X; Shen QK; Quan ZS
Eur J Med Chem; 2021 Aug; 220():113474. PubMed ID: 33930802
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and evaluation of HIF-1α inhibitory activities of novel panaxadiol derivatives.
Wang DY; Li YW; Zhang LH; Lv LY; Zhao YQ; Jin XJ; Piao HR
Bioorg Med Chem Lett; 2020 Dec; 30(24):127652. PubMed ID: 33130293
[TBL] [Abstract][Full Text] [Related]
10. Effects of trichostatin A on HIF-1α and VEGF expression in human tongue squamous cell carcinoma cells in vitro.
Kang FW; Que L; Wu M; Wang ZL; Sun J
Oncol Rep; 2012 Jul; 28(1):193-9. PubMed ID: 22552321
[TBL] [Abstract][Full Text] [Related]
11. Effects of YC-1 on hypoxia-inducible factor 1 alpha in hypoxic human bladder transitional carcinoma cell line T24 cells.
Li Y; Zhao X; Tang H; Zhong Z; Zhang L; Xu R; Li S; Wang Y
Urol Int; 2012; 88(1):95-101. PubMed ID: 22041818
[TBL] [Abstract][Full Text] [Related]
12. Kamebakaurin inhibits the expression of hypoxia-inducible factor-1α and its target genes to confer antitumor activity.
Wang KS; Ma J; Mi C; Li J; Lee JJ; Jin X
Oncol Rep; 2016 Apr; 35(4):2045-52. PubMed ID: 26781327
[TBL] [Abstract][Full Text] [Related]
13. Discovery of Novel Aryl Carboxamide Derivatives as Hypoxia-Inducible Factor 1α Signaling Inhibitors with Potent Activities of Anticancer Metastasis.
Liu M; Liang Y; Zhu Z; Wang J; Cheng X; Cheng J; Xu B; Li R; Liu X; Wang Y
J Med Chem; 2019 Oct; 62(20):9299-9314. PubMed ID: 31556611
[TBL] [Abstract][Full Text] [Related]
14. Cyclin-dependent kinase inhibitor, P276-00, inhibits HIF-1α and induces G2/M arrest under hypoxia in prostate cancer cells.
Manohar SM; Padgaonkar AA; Jalota-Badhwar A; Rao SV; Joshi KS
Prostate Cancer Prostatic Dis; 2012 Mar; 15(1):15-27. PubMed ID: 22083267
[TBL] [Abstract][Full Text] [Related]
15. Identification of novel antiangiogenic anticancer activities of deguelin targeting hypoxia-inducible factor-1 alpha.
Oh SH; Woo JK; Jin Q; Kang HJ; Jeong JW; Kim KW; Hong WK; Lee HY
Int J Cancer; 2008 Jan; 122(1):5-14. PubMed ID: 17764071
[TBL] [Abstract][Full Text] [Related]
16. Cucurbitacin B inhibits the translational expression of hypoxia-inducible factor-1α.
Ma J; Zi Jiang Y; Shi H; Mi C; Li J; Xing Nan J; Wu X; Joon Lee J; Jin X
Eur J Pharmacol; 2014 Jan; 723():46-54. PubMed ID: 24333213
[TBL] [Abstract][Full Text] [Related]
17. Boron-containing phenoxyacetanilide derivatives as hypoxia-inducible factor (HIF)-1alpha inhibitors.
Shimizu K; Maruyama M; Yasui Y; Minegishi H; Ban HS; Nakamura H
Bioorg Med Chem Lett; 2010 Feb; 20(4):1453-6. PubMed ID: 20083404
[TBL] [Abstract][Full Text] [Related]
18. Novel HIF-1α inhibitor CDMP-TQZ for cancer therapy.
Chu PC; Wu YC; Chen CY; Hung YS; Chang CS
Future Med Chem; 2021 Jun; 13(12):1057-1072. PubMed ID: 33896195
[No Abstract] [Full Text] [Related]
19. Magnolol suppresses hypoxia-induced angiogenesis via inhibition of HIF-1α/VEGF signaling pathway in human bladder cancer cells.
Chen MC; Lee CF; Huang WH; Chou TC
Biochem Pharmacol; 2013 May; 85(9):1278-87. PubMed ID: 23416116
[TBL] [Abstract][Full Text] [Related]
20. 1-[4-(N-Benzylamino)phenyl]-3-phenylurea derivatives as a new class of hypoxia-inducible factor-1alpha inhibitors.
Uno M; Ban HS; Nakamura H
Bioorg Med Chem Lett; 2009 Jun; 19(12):3166-9. PubMed ID: 19435661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
